BMY, HNST, HYZN, SAM INVESTOR ALERT BY CLAIMSFILER: Pending Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
BRISTOL-MYERS CVR INVESTORS: December 6, 2021 Filing Deadline in Class Action - Contact Lieff Cabraser Pharmaceutical Investing
Gilead Presents Long-Term Switch Data Reinforcing Biktarvy® as a Treatment Option for a Broad Range of People Living With HIV Biotech Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo + Chemotherapy for Patients with HER2 Negative, Advanced or Metastatic Gastric, Gastroesophageal Junction or Esophageal Adenocarcinoma ... Biotech Investing
INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits filed on behalf of APPH, BMY, EAR, HYZN Investors, Lead Plaintiff Deadlines Set Biotech Investing
The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to be Trained Biotech Investing
